Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Media Resources
2017
Joint Submission to European Commission Public Consultation on Horizon 2020
2016
Medicines Policy in Moldova
Fact or Fiction? What Healthcare Professionals Need to Know about Pharmaceutical Marketing
Prices and Availability of Locally Produced and Imported Medicines in Ethiopia
Prices and Availability of Locally Produced and Imported Medicines in Tanzania
Health Systems Advocacy Partnership: Fact Sheet
Press Release: Health Action International Receives €460,000 Grant from Dutch Ministry of Foreign Affairs to Fight Snakebite Death & Disability in Sub-Saharan Africa
Press Release: Health Action International Launches Educational Guide to Help EU Healthcare Students & Professionals Counter Ill Effects of Pharmaceutical Marketing
Joint Letter: Civil Society Urges US Secretary Burwell to Expand Access to Patented Cancer Drugs in Developing Countries
Press Release: Report Reveals Danger Of TTIP Locking Europe & Us Into Higher Drug Prices, Failed Pharma Innovation Model
Fact or Fiction: What Healthcare Professionals Need to Know about Pharmaceutical Marketing in the European Union
56 Non-profit Organisations Question US State Department Pressure Against Global Access to Medicines Initiatives – Letter to US Secretary of State, John Kerry
Recommendations for EU Governments to Improve Access & Innovation of Needed Medicines
Measures That Reduced Price of Patented HIV Medicines Should Be Used to Safeguard Access to New Essential Medicines
WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication
HAI Co-signs Letter to Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure
Snakebite: Call for urgent global action to end death & suffering
HAI, KEI & STOPAIDS Statement on the WHO Consultative Expert Working Group on R&D
Measuring Medicine Prices, Availability, Affordability and Price Components (2nd Ed.)
Civil Society Urges Member States to Support the Dutch EU Presidency’s Vision on Access to Affordable Medicines
Assessing EU Funding for R&D for Poverty-related and Neglected Diseases
HAI Intervention at the United Nations High-Level Panel on Access to Medicines
Access to High-priced Medicines in Hospital Settings in Europe: A Study in Four European Countries
Study Finds Access to High-priced Medicines May Differ Across EU
Why You Should Be Concerned About TTIP and Access to Medicines
European CSOs Call for Rejection of EU Trade Secrets Directive
2015